| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |